Home/Filings/4/0001493152-18-006784
4//SEC Filing

Schinazi Raymond F 4

Accession 0001493152-18-006784

CIK 0001412486other

Filed

May 13, 8:00 PM ET

Accepted

May 14, 4:01 PM ET

Size

15.0 KB

Accession

0001493152-18-006784

Insider Transaction Report

Form 4
Period: 2018-05-10
Schinazi Raymond F
Director10% Owner
Transactions
  • Exercise/Conversion

    Common Stock

    2018-05-10$1.90/sh+263,158$500,000985,384 total(indirect: By LP)
  • Award

    Common Stock

    2018-05-10$1.90/sh+10,209$19,397995,593 total(indirect: By LP)
  • Disposition to Issuer

    8% Convertible Note

    2018-05-10$500000.00/sh61,728$30,864,000,00061,728 total(indirect: By LP)
    Exercise: $8.10From: 2017-11-24Exp: 2019-11-24Common Stock (61,728 underlying)
  • Award

    8% Convertible Note

    2018-05-10$500000.00/sh+263,158$131,579,000,000263,158 total(indirect: By LP)
    Exercise: $1.90From: 2018-05-10Exp: 2019-11-24Common Stock (263,158 underlying)
  • Exercise/Conversion

    8% Convertible Note

    2018-05-10$500000.00/sh263,158$131,579,000,000263,158 total(indirect: By LP)
    Exercise: $1.90From: 2018-05-10Exp: 2019-11-24Common Stock (263,158 underlying)
Holdings
  • Common Stock

    9,240,928
Footnotes (4)
  • [F1]The amount of securities beneficially owned and the conversion prices have been adjusted for the one-for-30 reverse stock split effective January 24, 2018.
  • [F2]The reporting person was issued common stock in connection with the conversion of a convertible note, as amended, at $1.90 per share. See Table II for a description of the convertible note.
  • [F3]The reporting person was issued common stock in lieu of accrued interest owed in connection with the convertible note described in Table II.
  • [F4]In accordance with Rule 16b-3, in advance of the effectuation of the transactions reported, the issuer's board of directors approved an amendment to the convertible note held by the reporting person who is a director and 10% beneficial owner of the issuer. The amendment of the outstanding convertible note is reported as a cancellation of the "old" note and the grant of a replacement note.

Documents

1 file

Issuer

Cocrystal Pharma, Inc.

CIK 0001412486

Entity typeother

Related Parties

1
  • filerCIK 0001397607

Filing Metadata

Form type
4
Filed
May 13, 8:00 PM ET
Accepted
May 14, 4:01 PM ET
Size
15.0 KB